306 related articles for article (PubMed ID: 19049948)
1. Short course of infliximab for disfiguring lupus pernio.
Kiorpelidou D; Gaitanis G; Zioga A; Bassukas ID
Eur J Dermatol; 2008; 18(6):727-9. PubMed ID: 19049948
[No Abstract] [Full Text] [Related]
2. Successful long-term management of refractory cutaneous and upper airway sarcoidosis with periodic infliximab infusion.
Rosen T; Doherty C
Dermatol Online J; 2007 Jul; 13(3):14. PubMed ID: 18328208
[TBL] [Abstract][Full Text] [Related]
3. Infliximab therapy for sarcoidosis (lupus pernio).
Haley H; Cantrell W; Smith K
Br J Dermatol; 2004 Jan; 150(1):146-9. PubMed ID: 14746631
[TBL] [Abstract][Full Text] [Related]
4. Lupus pernio: successful treatment with a potent topical corticosteroid.
Khatri KA; Chotzen VA; Burrall BA
Arch Dermatol; 1995 May; 131(5):617-8. PubMed ID: 7741556
[No Abstract] [Full Text] [Related]
5. Refractory highly disfiguring lupus pernio: a dramatic and prolonged response to infliximab.
Blanco R; González-Gay MA; González-López MA; Fernández-Llaca H; González-Vela MC
Int J Dermatol; 2015 Aug; 54(8):e321-2. PubMed ID: 26147319
[No Abstract] [Full Text] [Related]
6. Recalcitrant cutaneous sarcoidosis responding to adalimumab but not to etanercept.
Field S; Regan AO; Sheahan K; Collins P
Clin Exp Dermatol; 2010 Oct; 35(7):795-6. PubMed ID: 20831604
[No Abstract] [Full Text] [Related]
7. [Cutaneous sarcoidosis (lupus pernio) with neuroendocrine involvement].
Bouscarat F; Sellem A; Girardin C; Hoang X; Crickx B; de Prost Y; Belaïch S
Ann Dermatol Venereol; 1991; 118(11):829-32. PubMed ID: 1789649
[No Abstract] [Full Text] [Related]
8. Lupus pernio.
Lugo-Janer G
Bol Asoc Med P R; 1990 Oct; 82(10):448-9. PubMed ID: 2080956
[No Abstract] [Full Text] [Related]
9. Infliximab as a steroid-sparing agent in refractory cutaneous sarcoidosis: single-center retrospective study of 9 patients.
Sené T; Juillard C; Rybojad M; Cordoliani F; Lebbé C; Morel P; Tazi A; Guibal F
J Am Acad Dermatol; 2012 Feb; 66(2):328-32. PubMed ID: 22243729
[No Abstract] [Full Text] [Related]
10. Recalcitrant cutaneous sarcoidosis responding to infliximab.
Heffernan MP; Anadkat MJ
Arch Dermatol; 2005 Jul; 141(7):910-1. PubMed ID: 16027318
[No Abstract] [Full Text] [Related]
11. The treatment of lupus pernio: results of 116 treatment courses in 54 patients.
Stagaki E; Mountford WK; Lackland DT; Judson MA
Chest; 2009 Feb; 135(2):468-476. PubMed ID: 18812454
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous tuberculosis revealed by infliximab therapy for presumed sarcoidosis.
Fraser SJ; Hill AT; McKay DA; Reid WA; Mathers ME; MacDougall G; Schofield OM
Clin Exp Dermatol; 2010 Jun; 35(4):e141-2. PubMed ID: 19886968
[No Abstract] [Full Text] [Related]
13. Disfiguring cutaneous manifestation of sarcoidosis treated with thalidomide: a case report.
Lee JB; Koblenzer PS
J Am Acad Dermatol; 1998 Nov; 39(5 Pt 2):835-8. PubMed ID: 9810910
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous sarcoidosis and infliximab: evidence for efficacy in refractory disease.
Tu J; Chan J
Australas J Dermatol; 2014 Nov; 55(4):279-81. PubMed ID: 23651297
[TBL] [Abstract][Full Text] [Related]
15. Morpheaform sarcoidosis.
Ginarte M; Zulaica A; Toribio J
Acta Derm Venereol; 2006; 86(3):264-5. PubMed ID: 16710595
[No Abstract] [Full Text] [Related]
16. Successful treatment of lupus pernio with adalimumab.
Judson MA
Arch Dermatol; 2011 Nov; 147(11):1332-3. PubMed ID: 22106129
[No Abstract] [Full Text] [Related]
17. Lupus pernio with 2 years of preceding symptomatic gastric sarcoidosis.
Mizuno K; Kato N; Sugihara A; Okamoto H
J Dermatol; 2015 Mar; 42(3):330-1. PubMed ID: 25572275
[No Abstract] [Full Text] [Related]
18. Chronic facial sarcoidosis including lupus pernio: clinical description and proposed scoring systems.
Baughman RP; Judson MA; Teirstein A; Lower EE; Lo K; Schlenker-Herceg R; Barnathan ES
Am J Clin Dermatol; 2008; 9(3):155-61. PubMed ID: 18429644
[TBL] [Abstract][Full Text] [Related]
19. Sarcoidosis mimicking malar rash: a case of lupus pernio.
Sato R; Kiniwa Y; Shirai T; Okuyama R
Eur J Dermatol; 2019 Jun; 29(3):331-332. PubMed ID: 31145098
[No Abstract] [Full Text] [Related]
20. Cutaneous Rosai-Dorfman disease successfully treated with low-dose methotrexate.
Sun NZ; Galvin J; Cooper KD
JAMA Dermatol; 2014 Jul; 150(7):787-8. PubMed ID: 24789266
[No Abstract] [Full Text] [Related]
[Next] [New Search]
